Quick Answer
DOT drug testing = federal law under 49 CFR Part 40, requiring certified collectors, the Federal CCF, SAMHSA-certified labs, and MRO review for safety-sensitive employees at regulated employers. Non-DOT testing = employer policy, with no federal procedure required. Using the wrong form for the wrong test type is a compliance violation in either direction.
“Is this a DOT test or a non-DOT test?” — it’s one of the first questions a certified collector should ask every time an authorization form comes in. The answer changes everything: which form to use, which procedure to follow, whether an MRO review is required, and whether your DOT certification even applies. This article breaks down exactly what makes a drug test “DOT,” what makes one “non-DOT,” and why getting them mixed up is a compliance violation.
The Short Answer
A DOT drug test is federally mandated under 49 CFR Part 40 for employees in safety-sensitive roles at DOT-regulated employers — commercial truck drivers, airline pilots, railroad workers, and others. Every step of the process is governed by federal regulation: who collects the specimen, which form is used, which lab tests it, and who reviews the result.
A non-DOT drug test is employer-discretionary. The company decides when to test, why to test, and how to conduct it. No federal procedure is required. State law may apply, but there is no single federal framework comparable to 49 CFR Part 40 governing the collection.
In short: DOT testing = federal law. Non-DOT testing = employer policy.
What Makes a Drug Test “DOT”?
A test qualifies as a DOT drug test when all of the following conditions are true:
- Ordered by a DOT-regulated employer. The employer is subject to at least one of the six DOT operating agencies: FMCSA (trucking), FAA (aviation), FRA (railroad), FTA (transit), PHMSA (pipeline), or USCG (maritime).
- Covers a safety-sensitive function. The employee being tested performs a role specifically identified as safety-sensitive under the applicable agency’s regulations — for example, operating a commercial motor vehicle under FMCSA rules, or performing safety-sensitive aviation maintenance under FAA rules.
- Follows 49 CFR Part 40 procedures exactly. The collection must use the Federal Custody and Control Form (CCF), follow the prescribed steps under Subparts E through H, and be conducted by a qualified, trained collector.
- Tested at a SAMHSA-certified laboratory. Only labs certified by the Substance Abuse and Mental Health Services Administration (SAMHSA) — also called HHS-certified labs — are authorized to test DOT specimens. No exceptions.
- Reviewed by a licensed Medical Review Officer (MRO). Every DOT result — including negatives — is reviewed by a physician licensed as an MRO before the employer receives it. The MRO is the gatekeeper between the lab result and the employer.
All five conditions must be present. A test that skips the Federal CCF, uses an uncertified lab, or bypasses MRO review is not a valid DOT test — even if the employer intended it to be one.
What Makes a Test “Non-DOT”?
Non-DOT testing is any workplace drug test that falls outside the Part 40 framework. This includes:
- Tests ordered by employers who are not subject to any DOT agency (a retail company, a restaurant chain, a local law firm, a hospital).
- Tests ordered by DOT-regulated employers for employees who do not perform safety-sensitive functions (office staff, HR, accounting personnel at a trucking company, for example).
In a non-DOT test, the employer decides when to test (pre-employment, random, post-accident, reasonable suspicion, return-to-duty), why to test, and how to structure the program. State law may impose requirements — some states restrict random testing, require specific notice periods, or mandate certain procedures — but there is no federal collection procedure equivalent to Part 40.
Key distinctions: there is no federal MRO requirement for non-DOT tests. The collector is not required to be DOT-certified. No Federal CCF is required — the employer typically provides its own chain-of-custody form or uses a form provided by its Third Party Administrator (TPA). That said, many employers voluntarily use certified collectors and follow Part 40-style procedures for consistency and defensibility — but that is employer policy, not federal law.
The Five-Panel Difference
DOT drug tests always use the same federally mandated five-panel (5-panel) test. The panel is fixed by regulation and cannot be expanded or reduced by the employer. The five drug classes tested in every DOT urine specimen are:
Marijuana
THC metabolites
Cocaine
Benzoylecgonine
Amphetamines
Including methamphetamine, MDMA
Opioids
Codeine, morphine, heroin, oxycodone, oxymorphone, hydrocodone, hydromorphone
PCP
Phencyclidine
Non-DOT panels vary widely. An employer may choose a standard 5-panel test that mirrors the DOT panel, a 10-panel test that adds barbiturates, benzodiazepines, methadone, propoxyphene, and Quaalude, a 12-panel test, or a fully custom panel configured for their industry or workforce. The employer — or its TPA — specifies the panel when ordering the test. As a collector, you test what the order specifies; you do not determine the panel.
The practical implication: A donor who is told they passed a “DOT test” has been tested for exactly five drug classes. A donor who passed a non-DOT 10-panel test has been tested for ten. These are not the same thing, and conflating them creates confusion for employers and donors alike.
Collection Procedure Differences
The collection procedure is where the differences between DOT and non-DOT are most operationally significant for collectors. Here is a side-by-side breakdown:
| Requirement | DOT Test | Non-DOT Test |
|---|---|---|
| Collection procedure | Strict Part 40 steps (§§ 40.61–40.73) | Employer-determined; no federal standard |
| Chain-of-custody form | Federal CCF required | No standardized form required; employer or TPA form used |
| Collector certification | Required — qualified, trained DOT collector | Optional; employer may require certification voluntarily |
| Split specimen | Mandatory — A/B bottles (30 mL / 15 mL) | No mandated split; single specimen is common |
| Laboratory | SAMHSA/HHS-certified lab only | Any CLIA-certified lab; SAMHSA certification not required |
| MRO review | Required for all results | Not federally required; employer may opt in |
| Governing authority | 49 CFR Part 40 (federal law) | Employer policy + applicable state law |
For a deep dive on the Federal CCF and DOT chain-of-custody documentation, see our dedicated guide covering every step from collection initiation to lab shipment.
Who Is Subject to DOT Testing?
DOT drug testing applies to employees in safety-sensitive functions at employers regulated by one of the six DOT operating agencies. Here is who falls under each:
FMCSA — Federal Motor Carrier Safety Administration
Commercial motor vehicle (CMV) drivers holding a commercial driver’s license (CDL). Covers operators of vehicles over 26,000 lbs GVWR, vehicles transporting 16+ passengers, and hazardous materials vehicles requiring placarding. The largest DOT-regulated testing population.
FAA — Federal Aviation Administration
Pilots (commercial and air carrier), air traffic controllers, flight attendants, aircraft dispatchers, and aviation maintenance technicians performing safety-sensitive functions under FAA regulations.
FRA — Federal Railroad Administration
Railroad workers in covered service: locomotive engineers, conductors, train dispatchers, signal employees, and maintenance-of-way workers performing safety-sensitive functions.
FTA — Federal Transit Administration
Transit operators, controllers, mechanics, and armed security personnel at FTA-funded transit agencies (bus, subway, light rail systems that receive federal funding).
PHMSA — Pipeline and Hazardous Materials Safety Administration
Operations, maintenance, and emergency-response employees at gas, hazardous liquid, and liquefied natural gas pipeline operators subject to PHMSA regulations.
USCG — U.S. Coast Guard
Crewmembers of regulated vessels, including persons holding USCG-issued merchant mariner credentials and anyone who operates or performs safety-sensitive duties aboard regulated commercial vessels.
Notice what’s missing from that list: office employees at a trucking company, warehouse workers, construction laborers, retail employees, healthcare workers, and millions of other job categories are generally not subject to DOT testing — even if their employer is in a regulated industry — unless they personally perform a safety-sensitive function as defined by their agency.
Why Collectors Need to Know the Difference
Here’s a scenario that happens more often than collectors realize: an employer sends an employee to your collection site with a form that says “DOT test” — but the employee is not a CDL driver. They’re an administrative assistant at a trucking company, or a forklift operator, or a new hire who doesn’t hold a commercial license yet.
As a collector, you must ask for the regulation. Which DOT agency regulates this test? Under which specific rule is this employee being tested? If the employer or employee can’t name the applicable regulation and confirm the employee’s safety-sensitive function, you are very likely looking at a non-DOT test — or an employer who mistakenly ordered a DOT test for a non-regulated employee.
Why does this matter? Because using the Federal CCF for a non-DOT test creates a compliance problem for the employer — the CCF is a federal form that implies federal regulatory authority. Using non-DOT documentation for an actual DOT test creates a different compliance problem: the collection will be invalid because the required chain-of-custody form was not used. Mixing up the two is a compliance violation in either direction.
The practical rule: when in doubt, ask. Confirm the authorization form, the agency, and the safety-sensitive function before starting any collection. Document the authorization information in Step 1 of the CCF for DOT tests. For non-DOT tests, use the employer’s designated chain-of-custody form and follow the employer’s documented procedures.
For more on what happens downstream after a DOT collection — including the MRO review process and what different result types mean — see our guide on what happens after a non-negative DOT drug test result.